PreImplantation Factor (PIF) reverses paralysis and regenerates nerve tissue in EAE (MS) model.13 US patents, human trials 2013. Non-toxic.
BioIncept is planning human trials of PreImplantation Factor (PIF), a human peptide secreted by 2 cell embryos. PIF enables selective regulation of the immune system to accept the embryo while maintaining protection against disease. This selective immune control does not have the dangerous side effects of immune suppressants and is shown to reverse paralysis. PIF is targeted to treat immune and pregnancy disorders, and transplant rejection.